Inventor · disambiguated record
Kathy Miller
Also filed as: MILLER KATHY · MILLER KATHY D · MILLER KATHY L · MILLER KATHY LYNN
10 granted patents·17 pending applications·71 citations·filing 2001–2023
89Inventor score
Top patents by PatentIndex Score
27 records- 0193US8722859B2Multivalent antibodies and uses thereforMILLER KATHY L·Filed 2012·Granted May 13, 2014·30 cites·4 claims
- 0292US9789203B2cKIT antibody drug conjugatesABRAMS TINYA·Filed 2014·Granted Oct 17, 2017·11 cites·31 claims
- 0391US11306144B2B7-H4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Apr 19, 2022·6 cites·45 claims
- 0491US9493579B2Multivalent antibodies and uses thereforGENENTECH INC·Filed 2014·Granted Nov 15, 2016·11 cites·13 claims
- 0590US11814431B2B7-H4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Nov 14, 2023·3 cites·48 claims
- 0687US10117953B2Antibody drug conjugatesNOVARTIS AG·Filed 2016·Granted Nov 6, 2018·2 cites·15 claims
- 0787US9498543B2Antibody drug conjugatesABRAMS TINYA·Filed 2014·Granted Nov 22, 2016·5 cites·15 claims
- 0881US2024043542A1B7-h4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0978US10005836B2Antibody drug conjugatesABRAMS TINYA·Filed 2015·Granted Jun 26, 2018·3 cites·22 claims
- 1075US2020129632A1Antibody drug conjugatesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1172US2023013293A1B7-h4 antibodies and methods of use thereofFIVE PRIME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1269US2022403009A1Multimeric coronavirus binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1365US2018125996A1Antibody drug conjugatesNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1464US2023058162A1Multimeric coronavirus binding molecules and uses thereofIGM BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1559US10626172B2Antibody drug conjugatesABRAMS TINYA·Filed 2018·Granted Apr 21, 2020·0 cites·5 claims
- 1659US2015320880A1Antibody drug conjugatesABRAMS TINYA·Filed 2015·Application pending·0 cites
- 1759US2006025576A1Multivalent antibodies and uses thereforGENENTECH INC·Filed 2005·Application pending·0 cites
- 1859US2010135998A1Combination therapy for treatment of immune disordersSCHERING CORP·Filed 2008·Application pending·0 cites
- 1958US2008299120A1Multivalent antibodies and uses thereforMILLER KATHY L·Filed 2006·Application pending·0 cites
- 2056US2011110852A1Multivalent Antibodies and Uses ThereforGENENTECH INC·Filed 2010·Application pending·0 cites
- 2154US11939383B2B7-H4 antibodies and methods and use thereofFIVE PRIME THERAPEUTICS INC·Filed 2020·Granted Mar 26, 2024·0 cites·17 claims
- 2254US2013287775A1Combination therapy for treatment of immune disordersMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2354US2005064455A1Gene expression markers for predicting response to chemotherapyFiled 2004·Application pending·0 cites
- 2452US2002004587A1Multivalent antibodies and uses thereforGENENTECH INC·Filed 2001·Application pending·0 cites
- 2545US2012156699A1Pathogenic TH17 Cells; related reagents and methodsBOWMAN EDWARD P·Filed 2012·Application pending·0 cites
- 2639US2019194315A1Antibody drug conjugatesABRAMS TINYA·Filed 2016·Application pending·0 cites
- 2728US2012201823A1April antagonists and methods of useJANATPOUR MARY J·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathy Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →